First Author: A.Akinci TURKEY
Co Author(s): O. Muftuoglu
Purpose:
To evaluate the results of phacoemulsification with intravitreal triamcinolone acetonide (TA) injection in patients with diabetic macular edema and cataract.
Setting:
Kudret eye hospital
Methods:
The records of 17 patients with diabetic macular edema and lens opacities which would interfere with macular laser photocoagulation, who have undergone phacoemulsification with intravitreal injection of 4 mg TA, were retrospectively evaluated. All patients have undergone focal or modified grid laser photocoagulation one month after the surgery. All patients were evaluated by spectral OCT/OCT SLO before, 1 and 3 months after the surgery beyond complete ophthalmologic examination. The best corrected visual acuity (BCVA) levels and central macular thickness (CMT) recorded at 1st and 3rd months after the surgery were compared with the initial values. Paired samples t test was used for statistical analysis.
Results:
Results:The mean initial BCVA was 0.19±0.07 (0.05-0.2). The mean BCVA at 1 and 3 months after the surgery were 0.53±0.21 (SD) (0,3-0,6), 0.57±0.18 (SD) (0,3-0,7). The BCVA level recorded at 1st and 3 months after the surgery were significantly higher than the initial BCVA (p=0.019). The mean initial CMT was 375.2±98.5 microns. The mean CMT at 1 and 3 months after the surgery were 301±43.2 and 282.5±45.3 microns. The CMT recorded at 1st and 3 months after the surgery were significantly lower than the initial CMT (p<0.001, p<0.001).
Conclusions:
Phacoemulsification with intravitreal injection of TA provides a decrease in central macular thickness with a gain in best corrected visual acuity in patients with diabetic macular edema and lens opacities. FINANCIAL DISCLOSURE?: No
Please wait while information is loading.
